mhurhangee/ep-ind-claims huggingface dataset:
Connection device for electrically contact-connecting electrically conductive connection lugs (2, 3) or connection contacts of electrically conductive elements of planar design, in particular for contact-connecting planar photovoltaic elements, which connection device has the following components: a) a flat carrier plate consisting of non-conductive material and preferably in the form of a rectangular, flat component frame, b) at least one conductor plate (5, 6) connected to the carrier plate, wherein - the conductor plate has connections (7, 8) for contact-connecting at least one continuing electric conductor or cable (9, 10), and wherein - at least one connection region (11, 12) for contact-connecting at least one of the connection lugs (2, 3) or connection contacts is provided on the conductor plate, wherein the connection device furthermore has a contact component made of non-conductive material which electrically and mechanically connects the connection lugs (2, 3) or connection contacts to the conductor plate (5, 6), wherein the carrier plate is formed from plastic, characterized in that the conductor plates (5, 6) and the connections (7, 8) for contact-connecting continuing electric conductors or cables (9, 10) are connected to the carrier plate by deforming parts of the carrier plate, wherein the deforming is realized by way of hot caulking, and wherein the connection device is entirely encapsulated in an electrically insulating plastic material. a) a flat carrier plate consisting of non-conductive material and preferably in the form of a rectangular, flat component frame, b) at least one conductor plate (5, 6) connected to the carrier plate, wherein - the conductor plate has connections (7, 8) for contact-connecting at least one continuing electric conductor or cable (9, 10), and wherein - at least one connection region (11, 12) for contact-connecting at least one of the connection lugs (2, 3) or connection contacts is provided on the conductor plate, - the conductor plate has connections (7, 8) for contact-connecting at least one continuing electric conductor or cable (9, 10), and wherein - at least one connection region (11, 12) for contact-connecting at least one of the connection lugs (2, 3) or connection contacts is provided on the conductor plate,
A light receiving element comprising: a plurality of pixels; a photoelectric converter that includes a compound semiconductor material, is provided as a layer common to the plurality of pixels, and has a stacked structure in which a photoelectric conversion layer, a first contact layer, and a second contact layer are stacked, the photoelectric conversion layer being provided between the first contact layer and the second contact layer; further characterised by an insulating layer provided over the photoelectric converter; and a transparent electrode layer provided over the insulating layer. a plurality of pixels; a photoelectric converter that includes a compound semiconductor material, is provided as a layer common to the plurality of pixels, and has a stacked structure in which a photoelectric conversion layer, a first contact layer, and a second contact layer are stacked, the photoelectric conversion layer being provided between the first contact layer and the second contact layer; further characterised by an insulating layer provided over the photoelectric converter; and a transparent electrode layer provided over the insulating layer.
A catheter system for positioning a second guide wire adjacent to a first guide wire, said first guide wire located within a lumen in a living being, said catheter system comprising: an exchange catheter having at least first and second separate lumen segments, said first lumen segment being slidably arranged over the first guide wire to guide said catheter system along the first guide wire, said second lumen segment being slidably arranged over the second guide wire, characterized in that said catheter system further comprises a securement mechanism arranged to be engaged and disengaged, and while in an engaged position said securement mechanism releasably holds the second guide wire in a fixed position relative to a portion of said exchange catheter, and said first and second lumen segments are separate from each other in that they do not share the same axis. an exchange catheter having at least first and second separate lumen segments, said first lumen segment being slidably arranged over the first guide wire to guide said catheter system along the first guide wire, said second lumen segment being slidably arranged over the second guide wire, characterized in that said catheter system further comprises a securement mechanism arranged to be engaged and disengaged, and while in an engaged position said securement mechanism releasably holds the second guide wire in a fixed position relative to a portion of said exchange catheter, and said first and second lumen segments are separate from each other in that they do not share the same axis.
A method of making a coated abrasive article comprising sequential steps: a) disposing a curable composition on a major surface of a backing, wherein the backing has first and second opposed major surfaces, wherein the curable composition comprises a phenolic resin component, a free-radically polymerizable component, and an organic polymeric rheology modifier, wherein the organic polymeric rheology modifier comprises an alkali-swellable/soluble polymer, and wherein, on a solids basis, the organic polymeric rheology modifier comprises from 0.001 to 5 weight percent of the phenolic resin component, the free-radically polymerizable component, and the organic polymeric rheology modifier combined; b) adhering abrasive particles to the curable composition; c) at least partially curing the free-radically polymerizable component; and d) at least partially curing the phenolic resin component to provide an at least partially cured composition. a) disposing a curable composition on a major surface of a backing, wherein the backing has first and second opposed major surfaces, wherein the curable composition comprises a phenolic resin component, a free-radically polymerizable component, and an organic polymeric rheology modifier, wherein the organic polymeric rheology modifier comprises an alkali-swellable/soluble polymer, and wherein, on a solids basis, the organic polymeric rheology modifier comprises from 0.001 to 5 weight percent of the phenolic resin component, the free-radically polymerizable component, and the organic polymeric rheology modifier combined; b) adhering abrasive particles to the curable composition; c) at least partially curing the free-radically polymerizable component; and d) at least partially curing the phenolic resin component to provide an at least partially cured composition.
System for purifying/treatment of an organic material, waste and/or sewage under pressure, the system comprising: - a sealable pressure vessel provided with an inlet to supply an influent to be purified and/or treated whereby the pressure vessel is equipped to execute an anaerobe conversion of the influent in, amongst others, biogas; - at least one exhaust (3,16) to drain off products from the pressure vessel; - a control system to control the purifying process; - a pump that is functionally connected to the inlet for supplying the influent to be purified and/or treated; and - energy generating means to regulate and/or regenerate energy with, at least, a part of the produced biogas, characterized in that the pump can be driven by the biogas from the pressure vessel, thereby using the biologically built up pressure and converting it into usable energy in the form of labor, and wherein the system is a closed energetic system, wherein the pump comprises a pneumatically driven pump, and wherein the control system is provided with regulating means to adjust the capacity of the pump to the pressure in the pressure vessel. - a sealable pressure vessel provided with an inlet to supply an influent to be purified and/or treated whereby the pressure vessel is equipped to execute an anaerobe conversion of the influent in, amongst others, biogas; - at least one exhaust (3,16) to drain off products from the pressure vessel; - a control system to control the purifying process; - a pump that is functionally connected to the inlet for supplying the influent to be purified and/or treated; and - energy generating means to regulate and/or regenerate energy with, at least, a part of the produced biogas,
Method for separating or purifying biomolecules by aqueous two-phase extraction by means of a first aqueous phase and a second aqueous phase, wherein during the separation at least a partial transition of the biomolecules into the second aqueous phase occurs, wherein a porous material is present, in which pores the second aqueous phase is present and wherein during the separation a solution of biomolecules in the second aqueous phase present in the pores of the porous material occurs, and wherein the porous material is a particulate material, wherein during the implementation of the separation or purification the second aqueous phase is present substantially in the pores of the porous material and prior and subsequently to the separation the first aqueous phase is substantially disposed outside the porous material, and wherein the biomolecules are selected from nucleic acids, antibiotics, amino acids, lipids, carbohydrates, metabolites, metabolites, inclusion bodies, metabolic products and all kinds of proteins. wherein during the implementation of the separation or purification the second aqueous phase is present substantially in the pores of the porous material and prior and subsequently to the separation the first aqueous phase is substantially disposed outside the porous material, and wherein the biomolecules are selected from nucleic acids, antibiotics, amino acids, lipids, carbohydrates, metabolites, metabolites, inclusion bodies, metabolic products and all kinds of proteins.
A compound of formula I or a pharmacologically acceptable salt thereof: for use in the treatment of a brain cancer selected from a MGMT positive astrocytic brain tumour, a metastatic brain cancer and primary CNS lymphoma.
A method of producing pancreatic hormone-producing cells, comprising subjecting human iPS cells or human ES cells to the following steps -: a step of cultivating iPS cells or ES cells in a medium containing a Rho kinase inhibitor a step of cultivating the cells obtained in the aforementioned step in a medium containing a GSK3 inhibitor a step of cultivating the cells obtained in the aforementioned step in a medium containing GSK3 inhibitor and an activator of activin receptor-like kinase-4,7 a step of forming a cell mass from the cells obtained in the aforementioned, and cultivating the cell mass in a suspension state in a medium a step of cultivating the cells obtained in the aforementioned step in a medium containing a retinoic acid receptor agonist, an inhibitor of AMP-activated protein kinase and/or activin receptor-like kinase-2,3,6, an inhibitor of activin receptor-like kinase-4,5,7 and a cell growth factor a step of cultivating the cells obtained in the aforementioned step, wherein the activator of of activin receptor-like kinase-4,7 in step is activin; the Rho kinase inhibitor in step is (+)- -trans-4-(1-aminoethyl)-N-(4-pyridyl)cyclohexanecarboxamide dihydrochloride; the GSK3 inhibitor in step and is (i) 6-[[2-[[4-(2,4-dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]ethyl]amino]nicotinonitrile and/or (ii)(2'Z,3'E)-6-bromoindirubin-3'-oxime; the retinoic acid receptor agonist in step is retinoic acid; the inhibitor of AMP-activated protein kinase and/or activin receptor-like kinase-2,3,6 in step is dorsomorphin; the inhibitor of activin receptor-like kinase-4,5,7 in step is 4-[4-(1,3-benzodioxol-5-yl)-5-(2-pyridinyl)-1H-imidazol-2-yl]-benzamide; the cell growth factor in step is basic fibroblast growth factor. a step of cultivating iPS cells or ES cells in a medium containing a Rho kinase inhibitor a step of cultivating the cells obtained in the aforementioned step in a medium containing a GSK3 inhibitor a step of cultivating the cells obtained in the aforementioned step in a medium containing GSK3 inhibitor and an activator of activin receptor-like kinase-4,7 a step of forming a cell mass from the cells obtained in the aforementioned, and cultivating the cell mass in a suspension state in a medium a step of cultivating the cells obtained in the aforementioned step in a medium containing a retinoic acid receptor agonist, an inhibitor of AMP-activated protein kinase and/or activin receptor-like kinase-2,3,6, an inhibitor of activin receptor-like kinase-4,5,7 and a cell growth factor a step of cultivating the cells obtained in the aforementioned step, wherein
A hybrid automatic repeat request, HARQ, feedback method, comprising: receiving, by a first equipment, a data subframe transmitted by a second device, wherein the data subframe comprises a first slot corresponding to a first type of service and a second slot corresponding to a second type of service, and latency of the first type of service is lower than latency of the second type of service; generating, by the first equipment, a HARQ feedback according to the data subframe, wherein the HARQ feedback includes a first feedback bit corresponding to the first slot and a second feedback bit corresponding to the second slot; and transmitting, by the first equipment, the HARQ feedback to the second device, wherein the generating, by the first equipment, the HARQ feedback according to the data subframe comprises one of the followings: generating, by the first equipment, the first feedback bit according to number of the first slot and number of feedback bits, and generating the second feedback bit by binding the second slot according to number of residual feedback bits; or generating, by the first equipment, the first feedback bit according to number of the first slot and number of additional bits, and generating the second feedback bit by binding the second slot according to number of feedback bits. receiving, by a first equipment, a data subframe transmitted by a second device, wherein the data subframe comprises a first slot corresponding to a first type of service and a second slot corresponding to a second type of service, and latency of the first type of service is lower than latency of the second type of service; generating, by the first equipment, a HARQ feedback according to the data subframe, wherein the HARQ feedback includes a first feedback bit corresponding to the first slot and a second feedback bit corresponding to the second slot; and transmitting, by the first equipment, the HARQ feedback to the second device, wherein the generating, by the first equipment, the HARQ feedback according to the data subframe comprises one of the followings: generating, by the first equipment, the first feedback bit according to number of the first slot and number of feedback bits, and generating the second feedback bit by binding the second slot according to number of residual feedback bits; or generating, by the first equipment, the first feedback bit according to number of the first slot and number of additional bits, and generating the second feedback bit by binding the second slot according to number of feedback bits. generating, by the first equipment, the first feedback bit according to number of the first slot and number of feedback bits, and generating the second feedback bit by binding the second slot according to number of residual feedback bits; or generating, by the first equipment, the first feedback bit according to number of the first slot and number of additional bits, and generating the second feedback bit by binding the second slot according to number of feedback bits.
A method for predicting the presence of IRG1 and/or protein encoded by IRG1 in a subject, comprising the steps of: a- providing a biological sample isolated from said subject b- determining the presence and/or the level of itaconic acid in a biological sample, wherein the presence and/or the level of itaconic acid is indicative of the presence of IRG1 and/or of the protein encoded by IRG1, in at least a part of the cells of said biological sample. a- providing a biological sample isolated from said subject b- determining the presence and/or the level of itaconic acid in a biological sample,
A rotational atherectomy device comprising: an elongate flexible drive shaft (110, 410, 510, 610, 710, 910) defining a longitudinal axis (102, 402, 502, 602, 702), the drive shaft configured for rotation about the longitudinal axis, the drive shaft configured to be at least partially disposed within a lumen of an elongate flush tube of a system for performing rotational atherectomy to remove stenotic lesion material from a blood vessel when the system is used for performing the rotational atherectomy; an eccentric abrasive element that comprises multiple, side-by-side abrasive segments that are fixed to the drive shaft such that a center of mass of each of the abrasive segments is offset from the longitudinal axis, wherein the abrasive segments have a spherical shape; and a stability element (130, 430, 530, 630, 730, 930) that is fixed to the drive shaft and that has a center of mass aligned with the longitudinal axis, the stability element being distally spaced apart from the abrasive element, wherein a portion (112, 412, 512, 612) of the drive shaft is distal to the stability element, wherein the rotational atherectomy device is configured such that during rotation, the abrasive element orbits around the longitudinal; axis and the portion of the drive shaft that is distal to the distal stability element remains generally aligned with the longitudinal axis. an elongate flexible drive shaft (110, 410, 510, 610, 710, 910) defining a longitudinal axis (102, 402, 502, 602, 702), the drive shaft configured for rotation about the longitudinal axis, the drive shaft configured to be at least partially disposed within a lumen of an elongate flush tube of a system for performing rotational atherectomy to remove stenotic lesion material from a blood vessel when the system is used for performing the rotational atherectomy; an eccentric abrasive element that comprises multiple, side-by-side abrasive segments that are fixed to the drive shaft such that a center of mass of each of the abrasive segments is offset from the longitudinal axis, wherein the abrasive segments have a spherical shape; and a stability element (130, 430, 530, 630, 730, 930) that is fixed to the drive shaft and that has a center of mass aligned with the longitudinal axis, the stability element being distally spaced apart from the abrasive element, wherein a portion (112, 412, 512, 612) of the drive shaft is distal to the stability element, wherein the rotational atherectomy device is configured such that during rotation, the abrasive element orbits around the longitudinal; axis and the portion of the drive shaft that is distal to the distal stability element remains generally aligned with the longitudinal axis.
Exhaust-gas-aftertreatment system for an internal combustion engine, comprising an exhaust-gas system with an exhaust-gas channel in which at least two exhaust-gas-aftertreatment components (30, 36) for selective catalytic reduction of nitrogen oxides are arranged, wherein the first exhaust-gas-aftertreatment component for selective catalytic reduction of nitrogen oxides is arranged directly downstream of a turbine of an exhaust-gas turbocharger and, downstream of the first exhaust-gas-aftertreatment component for selective catalytic reduction of nitrogen oxides and upstream of the second exhaust-gas-aftertreatment component for selective catalytic reduction of nitrogen oxides, there is provided a burner by way of which the exhaust gas is heatable prior to entering the second exhaust-gas-aftertreatment component for selective catalytic reduction of nitrogen oxides, wherein, downstream of the second exhaust-gas-aftertreatment component for selective catalytic reduction of nitrogen oxides, there is arranged an oxidation catalytic converter for conversion of unburned hydrocarbons, characterized in that the first exhaust-gas-aftertreatment component is a particle filter with a coating for selective catalytic reduction of nitrogen oxides, and the second exhaust-gas-aftertreatment component is an SCR catalytic converter.
A laminated body, comprising: a solid electrolyte layer; and a layer containing a heat-resistant resin and an ion-conductive material, the solid electrolyte layer and the layer containing the heat-resistant resin and the ion-conductive material being adjacent to each other. a solid electrolyte layer; and a layer containing a heat-resistant resin and an ion-conductive material, the solid electrolyte layer and the layer containing the heat-resistant resin and the ion-conductive material being adjacent to each other.
A method of positioning a stent (10, 600, 150, 540, 850) on a delivery system, the delivery system comprising an inner catheter (42, 520), a sheath (44, 510), and a bumper (14, 50, 60, 610, 70, 100, 680, 200, 250, 300, 350, 600, 530) loaded onto the inner catheter (42, 520), the bumper (14, 50, 60, 610, 70, 100, 680, 200, 250, 300, 350, 600, 530) including a body portion (30, 76, 104, 684, 220, 270, 320, 370, 620, 354) and a bumper retainer (12, 52, 62, 608, 72, 106, 686, 230, 280, 330, 380, 630, 536) that protrudes radially from the body portion (30, 76, 104, 684, 220, 270, 320, 370, 620, 354) for precluding the stent (10, 600, 150, 540) from moving distally as the sheath (44, 520) is withdrawn during delivery of the stent (10, 600, 150, 540), characterized in that the method includes the step of interdigitating a cell (22, 601, 148, 542, 544) of the stent (10, 600, 150, 540) with the bumper retainer (12, 52, 62, 608, 72, 106, 686, 230, 280, 330, 380, 630, 536) is carried out without reducing a diameter of the stent (10, 600, 150, 540) by two paddles (20, 602, 152, 672) included in the cell of the stent (10, 600, 150, 540, 850) which flex to extend around the bumper retainer (12, 52, 62, 608, 72, 106, 686, 230, 280, 330, 380, 630) when pushing the stent (10, 600, 150,) in an axial direction against the bumper retainer (12, 52, 62, 608, 72, 106, 686, 230, 280, 330, 380, 630) wherein the cell is a partially open cell, or by expanding the bumper retainer (536, 810) to interdigitate with the cell (542, 544) of the stent. an inner catheter (42, 520), a sheath (44, 510), and a bumper (14, 50, 60, 610, 70, 100, 680, 200, 250, 300, 350, 600, 530) loaded onto the inner catheter (42, 520), the bumper (14, 50, 60, 610, 70, 100, 680, 200, 250, 300, 350, 600, 530) including a body portion (30, 76, 104, 684, 220, 270, 320, 370, 620, 354) and a bumper retainer (12, 52, 62, 608, 72, 106, 686, 230, 280, 330, 380, 630, 536) that protrudes radially from the body portion (30, 76, 104, 684, 220, 270, 320, 370, 620, 354) for precluding the stent (10, 600, 150, 540) from moving distally as the sheath (44, 520) is withdrawn during delivery of the stent (10, 600, 150, 540), characterized in that the method includes the step of interdigitating a cell (22, 601, 148, 542, 544) of the stent (10, 600, 150, 540) with the bumper retainer (12, 52, 62, 608, 72, 106, 686, 230, 280, 330, 380, 630, 536) is carried out without reducing a diameter of the stent (10, 600, 150, 540) by two paddles (20, 602, 152, 672) included in the cell of the stent (10, 600, 150, 540, 850) which flex to extend around the bumper retainer (12, 52, 62, 608, 72, 106, 686, 230, 280, 330, 380, 630) when pushing the stent (10, 600, 150,) in an axial direction against the bumper retainer (12, 52, 62, 608, 72, 106, 686, 230, 280, 330, 380, 630) wherein the cell is a partially open cell, or by expanding the bumper retainer (536, 810) to interdigitate with the cell (542, 544) of the stent.